Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06112067 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Aug 2026 → Nov 2026
See other at-risk trials from Shanghai Mental Health Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Aug 2026 to Nov 2026
    • Study completion pushed from Aug 2026 to Dec 2026
    • Study description expanded, about 152 words
    v4
  2. Notable Primary and study completion dates: Dec 2024 to Aug 2026v3
  3. Notable Primary endpoints revised (6)
    • Start date changed from estimate of Oct 2023 to Oct 16, 2023
    • Secondary endpoints revised (41)
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multi-center, single arm, prospective, open-label, extendable study for the efficacy and safety of combo-stim deep brain stimulation for treatment-refractory mental disorders (obsessive-compulsive disorder, schizophrenia, bipolar with depression, anorexia nervosa, gambling disorder and adult autism).
Trial Details
NCT Number NCT06112067
Lead Sponsor Shanghai Mental Health Center
Collaborators: SceneRay Corporation, Limited, Huashan Hospital, Shanghai 6th People's Hospital, Changhai Hospital
Conditions
(from sponsor)
Deep Brain Stimulation
Related terms Anorexia Nervosa, Autistic Disorder, Gambling, Obsessive-Compulsive Disorder, Schizophrenia
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov